DNA methylation alterations in endoscopic retrograde cholangiopancreatography brush samples of patients with suspected pancreaticobiliary disease.
about
Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levelsGenome-wide analysis of promoter methylation associated with gene expression profile in pancreatic adenocarcinoma.Pancreatic cancer DNMT1 expression and sensitivity to DNMT1 inhibitors.MicroRNA alterations of pancreatic intraepithelial neoplasiasComparison of KRAS mutation analysis and FISH for detecting pancreatobiliary tract cancer in cytology specimens collected during endoscopic retrograde cholangiopancreatographyPer-oral cholangioscopy.Bile proteomics for differentiation of malignant from benign biliary strictures: a pilot study.Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterations.Advances in biomarker research for pancreatic cancer.MSX2 in pancreatic tumor development and its clinical application for the diagnosis of pancreatic ductal adenocarcinomaPAM4 enzyme immunoassay alone and in combination with CA 19-9 for the detection of pancreatic adenocarcinomaCancer detection by ubiquitin carboxyl-terminal esterase L1 methylation in pancreatobiliary fluids.Epigenetics and epigenetic alterations in pancreatic cancer.The complexity of pancreatic ductal cancers and multidimensional strategies for therapeutic targeting.Promoter hypermethylation of SHOX2 and SEPT9 is a potential biomarker for minimally invasive diagnosis in adenocarcinomas of the biliary tract.Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease.Comprehensive review of the diagnosis and treatment of biliary tract cancer 2012. Part I: diagnosis-clinical staging and pathology.Beyond cytomorphology: expanding the diagnostic potential for biliary cytology.Hereditary pancreatic cancer: molecular bases and their application in diagnosis and clinical management: a guideline of the TTD group.Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma.Predicting the Grade of Dysplasia of Pancreatic Cystic Neoplasms Using Cyst Fluid DNA Methylation Markers.Epigallocatechin gallate inhibits the growth and promotes the apoptosis of bladder cancer cells.Peroral cholangioscopy in the new millennium.Lipidomic profiling of bile in distinguishing benign from malignant biliary strictures: a single-blinded pilot study.Identification of malignant cytologic criteria in pancreatobiliary brushings with corresponding positive fluorescence in situ hybridization results.Vascular endothelial growth factor levels in bile distinguishes pancreatic cancer from other etiologies of biliary stricture: a pilot study.Pancreatic CancerComparative effectiveness of pyruvate kinase M2 in bile, serum carbohydrate antigen 19-9, and biliary brushings in diagnosing malignant biliary strictures.Targeted multiprobe fluorescence in situ hybridization analysis for elucidation of inconclusive pancreatobiliary cytologyPredictors for detection of cancer in patients with indeterminate biliary stricture and atypical cells on endoscopic retrograde brush cytology
P2860
Q30502172-263E0E25-84CC-44D6-B771-D407BA49F00FQ30502257-18CAC7BF-03E5-4A66-8A9E-A7D98C166547Q34061112-A0916954-686A-4754-B6B7-9A288BABBBE8Q34082610-B7328755-A22D-4AE4-87F0-2151BA0E4368Q34239695-D3DA4ECA-9955-44F4-AAC3-70CFF218AA0EQ35106891-5F8CA34B-C6D4-46C3-976D-3B4C4F6A94C5Q35580127-E2C6C8CA-55AB-466F-B07F-DB947FAD957CQ36085799-1E805B4C-0CF7-4BF0-A376-AE5C0B0A90FAQ36126609-F90B6B50-AD9F-4A8A-B61E-96AF4B96E828Q36395433-E8BE74D3-1712-4C93-BA07-64C3EAC32A86Q36412915-6D71D302-35C7-4BE5-9C62-5898111DB247Q36715039-0E2091B3-E606-4AD0-B26C-FE703696E22BQ37041763-449044F6-CFA7-4360-A482-84EDFF33A997Q37156381-D229B14D-B2D7-4465-A016-1FEA148D2B9FQ37497846-47D7D1BB-4415-474A-A9E4-9E40AA5A226DQ37701805-5FC52AF5-995B-4F2A-BF43-BC3E834D8C89Q38001365-71310981-FBA8-411D-B281-981F9B553353Q38012419-1C20D6CC-60D2-427A-BD17-339778B692A4Q38031421-3CBCAA79-53E5-4672-BBDD-83B9860381B4Q40193200-C6A13A3C-E7A0-4B5E-B3C7-74C1FE0452DBQ40440052-8636F79D-E4C8-40D1-B295-609E5B1E2FF6Q42376314-30317707-F4A3-4015-A3E3-AF208FFCF7A0Q42563049-6DD1F3A5-10C4-44A0-BB1C-C2F3821BD246Q46020758-DD2E8F66-923C-4744-91A0-FE901E2BD5BAQ50436197-734D6263-FF12-43F4-AB0C-DD6674C579D1Q50857297-457DF85D-58FD-4647-955C-26D79F798DBFQ54135367-60F1A16B-896B-4A1E-AF74-FB427A7163BEQ54313456-9A8B0FCF-FF54-4220-BD5E-47B4D8C708DDQ57150712-219B30B3-84AE-4D3F-A9FF-2F9719A5983AQ57152722-43055582-68DF-41B6-81DD-10C95EE0E68B
P2860
DNA methylation alterations in endoscopic retrograde cholangiopancreatography brush samples of patients with suspected pancreaticobiliary disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
DNA methylation alterations in ...... ed pancreaticobiliary disease.
@en
type
label
DNA methylation alterations in ...... ed pancreaticobiliary disease.
@en
prefLabel
DNA methylation alterations in ...... ed pancreaticobiliary disease.
@en
P2093
P2860
P1476
DNA methylation alterations in ...... ed pancreaticobiliary disease.
@en
P2093
Chung-Pin Li
Mansour A Parsi
P2860
P304
P356
10.1016/J.CGH.2008.07.007
P407
P577
2008-09-05T00:00:00Z